- THYROCARE fell 11.25% to ₹457.50 at 12:34 IST on 30 Oct 2026.
- Volume so far was 10.26× its 20-session average.
- Q2 FY27 net profit: ₹15 crore, −68.17% on a year earlier.
Figures as of: 12:34 IST, Friday 30 October 2026
Thyrocare Technologies Ltd. (THYROCARE) fell 11.25% to ₹457.50 at 12:34 IST on Friday 30 October 2026. The trading volume reached 10.26× the 20-session average. The company filed Q2 FY27 results on Thursday 29 October 2026, and the stock traded lower on Friday. The reported net profit for the quarter was ₹15 crore.
THYROCARE share price today
| Price (12:34 IST) | ₹457.50 |
| Change from the previous close (₹515.50) | −₹58.00 (−11.25%) |
| Day’s range | ₹452.15 – ₹503.50 |
| Volume so far | 35.5 lakh shares |
| 20-session average daily volume | 3.5 lakh shares (volume so far is 10.26× that) |
| Closing prices of the previous 4 sessions | ₹463.15 – ₹494.50 |
| 52-week range (adjusted prices) | ₹342.55 – ₹662.00 |
| Price against that range | 30.9% below the high, 33.6% above the low |
| Market value at this price | ₹7,282 crore |
The share price traded between ₹452.15 and ₹503.50 during the session. Trading volume reached 35.5 lakh shares, which is 10.26× the 20-session average daily volume. The current price of ₹457.50 is 30.9% below the 52-week high of ₹662.00.
What has been announced
| When (IST) | Filing |
|---|---|
| Thu 29 Oct, 4:17 pm | Announcement under Regulation 30 (LODR)-Investor Presentation |
| Thu 29 Oct, 4:10 pm | Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Thu 29 Oct, 3:59 pm | Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026 |
| Thu 29 Oct, 3:54 pm | Board Meeting Outcome for Outcome Of The Board Meeting Held On October 29 2026 |
Q2 FY27 results at a glance
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Q1 FY27 | Change |
|---|---|---|---|---|---|
| Revenue from operations | 271 | 217 | +25.07% | 240 | +12.83% |
| Profit before tax | 34 | 63 | −46.23% | 68 | −50.72% |
| Net profit | 15 | 48 | −68.17% | 51 | −70.35% |
| Net profit as a share of revenue | 5.62% | 22.08% | – | 21.39% | – |
Revenue from operations for Q2 FY27 was ₹271 crore, which is +25.07% on a year earlier. Profit before tax reached ₹34 crore, a change of −46.23% on a year earlier. Net profit for the quarter was ₹15 crore, which is −68.17% on a year earlier.
How THYROCARE compares with its sector
| Change today | |
|---|---|
| THYROCARE | −11.25% |
| Nifty 50 | +0.68% |
The Hospital & Healthcare Services stock declined 11.25% while the Nifty 50 index was +0.68% at 12:34 IST. The company holds a market value of ₹7,282 crore. The stock price of ₹457.50 follows a range of ₹463.15 to ₹494.50 in the previous four sessions.
THYROCARE share price: FAQs
What is the THYROCARE share price today?
₹457.50 at 12:34 IST on Friday 30 October 2026, down ₹58.00 or 11.25% from the previous close of ₹515.50.
What were THYROCARE’s Q2 FY27 results?
Consolidated revenue from operations of ₹271 crore (+25.07% year on year) and net profit of ₹15 crore (−68.17%), for the quarter ended 30 September 2026.
When did THYROCARE announce the results?
The board meeting outcome was filed on Thu 29 Oct, 3:59 pm IST.
This article is for information only and is not investment advice. Prices are from the National Stock Exchange, filings from BSE announcements and results from the company’s reported figures. Calculations are by ThePip. Prices and figures move through the session; the time above says when these were read. Investments in securities are subject to market risks.